Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.510 USD | -4.43% |
|
-4.43% | -71.91% |
05/02 | Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease | RE |
04/02 | Enveric Biosciences Announces Closing Of $5 Million Public Offering | RE |